Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 87,273 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
cyclophosphamide
The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide.
H T Mouridsen, O Faber, L Skovsted
Cancer
. Feb, 1976.37(2):665-70 Print
Source:PubMed
PMID:
1253102
doi:10.1002/1097-0142(197602)37:2<665::aid-cncr2820370209>3.0.co;2-d
[Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide) (author's transl)].
G Voelcker, R Haeglsperger
Arzneimittelforschung
. 1982.32(6):639-47 Print
Source:PubMed
PMID:
7202370
doi:
Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin.
Priska Kaufmann, Manuel Haschke, Michael Török, Johannes Beltinger, Katrijn Bogman, Markus Wenk, Luigi Terracciano, Stephan Krähenbühl
Ther Drug Monit
. Dec, 2006.28(6):766-74 Print
Source:PubMed
PMID:
17164692
doi:10.1097/01.ftd.0000249943.85160.13
Effects of chlordiazepoxide, diazepam and oxazepam on the antitumor activity, the lethality and the blood level of active metabolites of cyclophosphamide and cyclophosphamide oxidase activity in mice.
K Sasaki, S Furusawa, G Takayanagi
J Pharmacobiodyn
. Oct, 1983.6(10):767-72 Print
Source:PubMed
PMID:
6141235
doi:10.1248/bpb1978.6.767
Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Ewa Kalinka-Warzocha, Jaroslaw Wajs, Ewa Lech-Maranda, Bernadetta Ceglarek, Jerzy Holowiecki, Irena Federowicz, Jan Walewski, Jaroslaw Czyz, Tadeusz Robak, Krzysztof Warzocha, Polish Lymphoma Research Group
Cancer
. Jul 15, 2008.113(2):367-75 Print
Source:PubMed
PMID:
18470902
doi:10.1002/cncr.23558
[Analysis of cardiac toxicity caused by cyclophosphamide in the H9c2 cell line and isolated and perfused rat hearts].
Seiji Nakamura, Manahito Aoki, Asami Mori, Tsutomu Nakahara, Kenji Sakamoto, Kunio Ishii
Gan To Kagaku Ryoho
. Apr, 2010.37(4):677-80 Print
Source:PubMed
PMID:
20414025
doi:
The effects of cyclophosphamide and its uroprotective agents, mesna and hyperbaric oxygen, on urinary bladder motility in guinea pigs.
V Sağmanligil, O Etlik, I Pişkin, A Tomur
Acta Vet Hung
. 1999.47(4):451-60 Print
Source:PubMed
PMID:
10641335
doi:10.1556/AVet.47.1999.4.5
Vomiting induced by cyclophosphamide and phosphoramide mustard in cats.
J H Fetting, L E McCarthy, H L Borison, M Colvin
Cancer Treat Rep
. Aug, 1982.66(8):1625-9 Print
Source:PubMed
PMID:
7105052
doi:
Cyclophosphamide for lupus during pregnancy.
M E B Clowse, L Magder, M Petri
Lupus
. 2005.14(8):593-7 Print
Source:PubMed
PMID:
16175930
doi:10.1191/0961203305lu2169oa
Residual marrow damage following therapy with cyclophosphamide.
W Fried, J Barone
Exp Hematol
. May, 1980.8(5):610-4 Print
Source:PubMed
PMID:
7007067
doi:
0
Previous
Next